Emanuela Cuomo
Executive Director, Global Head of Discovery Pharmacology Merck KGaA
Emanuela Cuomo is Global Head of Discovery Pharmacology at Merck KGaA, where she leads pharmacology strategies to support the discovery and development of innovative therapeutics. A highly experienced drug discovery leader with deep expertise in cancer biology, functional genomics, and target validation, Emanuela previously held a series of scientific leadership roles at AstraZeneca, where she led teams focused on CRISPR technologies, target identification and validation, drug discovery for undruggable and challenging targets, including molecular glue modalities. Prior to joining industry, she conducted cancer research at University College London and The Institute of Cancer Research. Her work has consistently focused on translating cutting-edge biology into new therapeutic approaches for patients with cancer.
Seminars
- Demonstrating how rational discovery approaches are enabling the identification of molecular glues and proximity-based therapeutics for targets and indications beyond oncology
- Exploring modality-agnostic strategies spanning molecular glues, PROTACs, and antibody-conjugated degraders to unlock new opportunities across autoimmune and neurological diseases
- Sharing lessons from advancing non-oncology degradation programs to accelerate the translation of induced proximity therapeutics into diverse disease areas
